In 2004, the Department of Health (DH) reported that as many as 17.5 million adults may be living with a chronic disease in the UK, while chronic diseases are the leading cause of illness burden and disability across the world (Welsh Assembly Government, 2007). At the same time, patients’ experience of the care provided by the NHS can be variable and the number of people affected by chronic dis...

BACKGROUND Rates of nonadherence to aromatase inhibitors (AIs) among Medicare beneficiaries with hormone receptor-positive early breast cancer are high. Out-of-pocket drug costs appear to be an important contributor to this and may be addressed by eliminating copayments and other forms of patient cost sharing. The authors estimated the incremental cost-effectiveness of providing Medicare benefi...

Introduction: Since ancient times Malaria in Iran has been considered as a serious health risk, especially in Hormozgan Province, as no other disease like Malaria has imposed irreparable financial and life losses to the country. Since saving costs in the healthcare sector comes as first priority in most countries, this study aims at launching a cost-effectiveness analysis on malaria diagnosis d...